Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030

Impact · against what's priced in

The article provides no catalyst for Eli Lilly as its core growth projections and valuation risks are already factored into the current stock price. Novo Nordisk's mention as a competitor is consistent with existing market expectations for the GLP-1 sector.

LLY+0.00

Already priced in

The price assumes

A deceleration in growth from the 44.7% just delivered down to the 30.2% the reverse-DCF requires